Microscopic polyangiitis involving the breast

Acta Clin Belg. 2011 Mar-Apr;66(2):139-41. doi: 10.2143/ACB.66.2.2062535.

Abstract

We report a case of a 76-year-old woman, presenting with a persistent dry cough, subfebrility, arthralgia and myalgia, weight loss and a breast lesion. She has elevated inflammatory parameters, impaired renal function with proteinuria, bilateral lung nodules on computed tomography scan (CT scan) and a suspect lesion on mammography. A diagnosis of microscopic polyangiitis with involvement of the breast is made based on clinical and radiographic findings, with positive auto-immune serology and histological confirmation. Although vasculitis of the breast is uncommon, this case illustrates that when a breast lesion is found, in combination with constitutional symptoms, we should think about the possibility of an anti-Neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Therefore it may be important to perform auto-immune serology in these cases before proceeding to major surgery.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects
  • Antibodies, Antineutrophil Cytoplasmic / blood*
  • Azathioprine / administration & dosage
  • Azathioprine / adverse effects
  • Breast Diseases / diagnosis*
  • Breast* / blood supply
  • Breast* / pathology
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunologic Factors / blood
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Mammography
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / adverse effects
  • Microscopic Polyangiitis* / diagnosis
  • Microscopic Polyangiitis* / drug therapy
  • Microscopic Polyangiitis* / immunology
  • Microscopic Polyangiitis* / physiopathology
  • Microvessels / pathology
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Antineutrophil Cytoplasmic
  • Immunologic Factors
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Azathioprine
  • Methylprednisolone